Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

The University at Albany and Virginia Commonwealth University were awarded a $6.5 million NIH grant to establish a federal ...

Fintel reports that on October 27, 2025, Citigroup downgraded their outlook for Avidity Biosciences (NasdaqGM:RNA) from Buy ...

Fintel reports that on October 28, 2025, Chardan Capital downgraded their outlook for Avidity Biosciences (NasdaqGM:RNA) from ...

A joint research team has discovered a new molecular switch that determines when plant leaves begin to age. The research team has identified for the first time a new mechanism in which RNA made from ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Cells contain a blueprint in the form of DNA that dictates what they can make.This blueprint is converted into a message, or mRNA, which is then ...

Scientists found a virus-like living entity in human bodies named "obelisks" - small loops of RNA, each a thousand genetic ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Avidity Biosciences (RNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In a statement over the weekend, Novartis said that it entered into an agreement with Avidity Biosciences, Inc.

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.